THAP11, a novel binding protein of PCBP1, negatively regulates CD44 alternative splicing and cell invasion in a human hepatoma cell line

详细信息	查看全文 | 推荐本文 |

• 作者：Wen-Xi Lian^a ; ^b ; ¹ ; Rong-Hua Yin^b ; ¹ ; Xiang-Zhen Kong^b ; ^c ; Tong Zhang^b ; ^c ; Xian-Hong Huang^a ; ^b ; Wei-Wei Zheng^b ; Yang Yang^d ; Yi-Qun Zhan^b ; Wang-Xiang Xu^b ; ^e ; Miao Yu^b ; Chang-Hui Ge^b ; Jun-Tang Guo^f ; Chang-Yan Li^b ; ^e ; ^{happylichy@yahoo.com.cn} ; Xiao-Ming Yang^a ; ^b ; ^c ; ^{xiaomingyang@sina.com}
• 关键词：THAP11 ; PCBP1 ; CD44 alternative splicing ; Cell invasion ; HCC
• 出版年：2012
• 期刊代码：70_00145793
• 类别：bio
• 出版时间：21 May, 2012
• 卷：586
• 期：10
• 页码：1431-1438
• 文件大小：1242 K

摘要

THAP11 is an essential factor involved in ES cell pluripotency and cell growth. Here, we identified THAP11 as a novel physiological binding partner of PCBP1. In HepG2 cells, THAP11 overexpression inhibited CD44 v6 expression and cell invasion. However, when deleting the binding domain with PCBP1 or endogenous PCBP1 was knocked down, THAP11 failed to inhibit CD44 v6 expression, indicating that THAP11 regulates CD44 v6 expression through interacting with PCBP1. In HCC patients, the expression of THAP11 mRNA significantly correlated with PCBP1 mRNA expression. Our results suggest a novel role of THAP11 in CD44 alternative splicing and hepatoma invasion.

Structured summary of protein interactions:

with by () with by (View Interaction: , ) and by ()